Cannabis Sativa, Inc. (CBDS)
OTCMKTS: CBDS · Delayed Price · USD
0.0170
+0.0007 (4.29%)
Apr 18, 2024, 2:23 PM EDT - Market closed

Company Description

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States.

The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology.

Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm.

The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles.

It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013.

Cannabis Sativa, Inc. is based in Mesquite, Nevada.

Cannabis Sativa, Inc.
Country United States
Industry Health Information Services
Sector Healthcare
Employees 6
CEO David M. Tobias

Contact Details

Address:
355 W Mesquite Blvd, C70
Mesquite, Nevada 89027
United States
Phone 323-420-8683
Website cannabissativainc.com

Stock Details

Ticker Symbol CBDS
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001360442
CUSIP Number 13764T105
ISIN Number US13764T1051
Employer ID 20-1898270
SIC Code 7200

Key Executives

Name Position
David M. Tobias Chief Executive Officer, Chief Financial Officer, President, Secretary and Director
Catherine J. Carroll Treasurer and Director
Carolyn Merrill Controller

Latest SEC Filings

Date Type Title
Apr 1, 2024 NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Feb 7, 2024 144 Filing
Feb 6, 2024 144/A Filing
Jan 31, 2024 144 Filing
Dec 29, 2023 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 20, 2023 10-Q Quarterly Report
Nov 14, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Sep 5, 2023 RW Filing
Aug 21, 2023 10-Q Quarterly Report
Aug 15, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB